Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BFI Finance Indonesia Tbk (BFIN) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

BFI Finance Indonesia TbkTrade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

BFI Finance Indonesia Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? BFI Finance Indonesia Tbk trades at Rp785 (market cap 12.03T, 12.2M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp244 (market cap 164.65B, 214.9K 24h volume). The key difference: BFI Finance Indonesia Tbk is far larger — about 73.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and BFI Finance Indonesia Tbk is more actively traded (12.2M versus 214.9K). Which is the better fit depends on your goals.

BFINOBAT
Market Cap
12.03T164.65B
Volume
12.2M214.9K
Lot
122K2.15K
Turnover
9.55B51.97M
Average Price
782.93241.85
Value
9.55B51.97M
Indicative Equilibrium Price
785240
Indicative Equilibrium Volume
5.52K100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BFIN
View details
OBAT
View details

About BFI Finance Indonesia Tbk

PT BFI Finance Indonesia Tbk (the Company) formerly PT. Bunas Finance Indonesia Tbk (the Company) was established as PT Manufacturers Hanover Leasing Indonesia on April 7, 1982 based on Notarial deed No. 57 of Kartini Muljadi, S.H., Notary in Jakarta. Presently, the Company is engaged in leasing, consumer financing and factoring of accounts receivable. And changed to BFI Finance Indonesia on 2001

Read more on BFIN

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT